Hertelendi, M.; Belguenani, O.; Cherfi, A.; Folitar, I.; Kollar, G.; Polack, B.D.
Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Adults with Inoperable or Metastatic Somatostatin Receptor-Positive Pheochromocytomas/Paragangliomas, Bronchial and Unknown Origin Neuroendocrine Tumors, and Medullary Thyroid Carcinoma: A Systematic Literature Review. Biomedicines 2023, 11, 1024.
https://doi.org/10.3390/biomedicines11041024
AMA Style
Hertelendi M, Belguenani O, Cherfi A, Folitar I, Kollar G, Polack BD.
Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Adults with Inoperable or Metastatic Somatostatin Receptor-Positive Pheochromocytomas/Paragangliomas, Bronchial and Unknown Origin Neuroendocrine Tumors, and Medullary Thyroid Carcinoma: A Systematic Literature Review. Biomedicines. 2023; 11(4):1024.
https://doi.org/10.3390/biomedicines11041024
Chicago/Turabian Style
Hertelendi, Marianna, Oulaya Belguenani, Azzeddine Cherfi, Ilya Folitar, Gabor Kollar, and Berna Degirmenci Polack.
2023. "Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Adults with Inoperable or Metastatic Somatostatin Receptor-Positive Pheochromocytomas/Paragangliomas, Bronchial and Unknown Origin Neuroendocrine Tumors, and Medullary Thyroid Carcinoma: A Systematic Literature Review" Biomedicines 11, no. 4: 1024.
https://doi.org/10.3390/biomedicines11041024
APA Style
Hertelendi, M., Belguenani, O., Cherfi, A., Folitar, I., Kollar, G., & Polack, B. D.
(2023). Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Adults with Inoperable or Metastatic Somatostatin Receptor-Positive Pheochromocytomas/Paragangliomas, Bronchial and Unknown Origin Neuroendocrine Tumors, and Medullary Thyroid Carcinoma: A Systematic Literature Review. Biomedicines, 11(4), 1024.
https://doi.org/10.3390/biomedicines11041024